Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts
July 20, 2021 at 10:48 AM EDT
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|